Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC)
Closed
Phase 3
This is a trial of pembrolizumab with stereotactic radiotherapy for early stage non small cell lung cancer.
Early stage cancer is cancer that is small and hasn’t spread.
It is for people who can’t have surgery to remove their non small cell lung cancer.
Recruitment start: 23 August 2019
Recruitment end: 30 November 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Ming Lee
Merck Sharp & Dohme Ltd
Last reviewed: 16 Feb 2024
CRUK internal database number: 16685
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
